Literature DB >> 32258714

Metformin interferes with glucose cellular uptake by both estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cell lines: PS156.

I Amaral1, C Silva1, A Correia-Branco1, F Martel1.   

Abstract

Entities:  

Year:  2017        PMID： 32258714      PMCID： PMC6806794          DOI： 10.1016/j.pbj.2017.07.102

Source DB:  PubMed          Journal:  Porto Biomed J        ISSN： 2444-8664


× No keyword cloud information.
  4 in total

Review 1.  Metformin and cancer: Between the bioenergetic disturbances and the antifolate activity.

Authors:  J A Jara; R López-Muñoz
Journal:  Pharmacol Res       Date:  2015-08-13       Impact factor: 7.658

2.  Metformin and reduced risk of cancer in diabetic patients.

Authors:  Josie M M Evans; Louise A Donnelly; Alistair M Emslie-Smith; Dario R Alessi; Andrew D Morris
Journal:  BMJ       Date:  2005-04-22

Review 3.  Breast cancer statistics, 2013.

Authors:  Carol DeSantis; Jiemin Ma; Leah Bryan; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2013-10-01       Impact factor: 508.702

Review 4.  Metformin: An anti-diabetic drug to fight cancer.

Authors:  Marie Daugan; Amélie Dufaÿ Wojcicki; Benoit d'Hayer; Vincent Boudy
Journal:  Pharmacol Res       Date:  2016-10-05       Impact factor: 7.658
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.